PanCO: Updated Results of an Open-Label, Single-Arm Pilot Study of OncoSil P-32 Microparticles in Combination with Standard-of-Care (SoC) Gemcitabine + Nab-Paclitaxel or FOLFIRINOX Chemotherapy in Unresectable Locally Advanced Pancreatic Cancer (uLAPC)
| Autor: | Chinenye Iwuji, Mehrdad Nikfarjam, Paul Ross, Alain Hendlisz, Nam Q. Nguyen, Daniel Croagh, David Turner, Nicole Wilson, Morteza Aghmesheh, Adnan Nagrial, Marion Harris, Daniel Kenny, Thankamma Ajithkumar, Harpreet Wasan |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Oncology
medicine.medical_specialty Chemotherapy Standard of care Hepatology business.industry FOLFIRINOX Endocrinology Diabetes and Metabolism medicine.medical_treatment Gastroenterology Gemcitabine Locally advanced pancreatic cancer Internal medicine medicine Open label business Nab-paclitaxel medicine.drug |
| Zdroj: | Pancreatology. 20:e16 |
| ISSN: | 1424-3903 |
| DOI: | 10.1016/j.pan.2020.10.007 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect